Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Updates in
BRAF V600E
-Mutated mCRC
9
Mins
March 2024
The BRAF V600E mutation occurs in 8–12% of patients with metastatic colorectal cancer, and is associated with poor prognosis. This…
Read more
17th November 2014
Rituximab and Other New Anti-CD20 MAbs for Non-Hodgkin’s Lymphoma Treatment
Non-Hodgkin’s lymphomas (NHLs) are a heterogeneous group of different haematological cancers with a wide range of aggressiveness. NHLs represent >80% of….
17th November 2014
Fundamental Principles of Raising an Antitumour Immune Response in Vivo: A Complex Model, a Case Report, and a Perspective
In preclinical model systems, the fundamental principles underlying a successful and durable anti-tumour immune response are well demonstrated.
17th November 2014
Immunotherapy of Cancer: Towards a New Era
In the past two decades, immunotherapy of cancer has developed into an established treatment option. At first, the development of monoclonal antibodies…
17th November 2014
Radiotherapy for Breast Cancer: How Can it Benefit from Advancing Technology?
There have been significant technological and technical advances in radiotherapy over the last 20 years. This paper presents the pertinent advances and…
17th November 2014
Management of Patients with High-Grade Glioma
The scientific basis for the surgical management of patients with glioma is rapidly evolving. The infiltrative nature of these cancers precludes a…
17th November 2014
State-Of-The-Art Treatment in Castration-Resistant Prostate Cancer
Prostate cancer (PrCa) is the most common cancer type in men in developed countries. In the last few years, a dramatic change has occurred in the…
4
Mins
17th October 2014
Zydelig® (idelalisib): The Force to Fight CLL and FL
After the European Commission granted the marketing authorisation for Gilead’s Zydelig® (idelalisib), a first-in-class oral treatment for chronic…
2
Mins
12th February 2014
Cracking the Cancer-Code
The world of medicine and science changed forever the day scientists Watson and Crick discovered the structure of the double helix of DNA, which underpins..
Loading posts...
« Previous
1
…
22
23
24
25
26
Next »